PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancer-Reference-Cited by-同舟云学术

PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancer

Published:2022-02 Issue:2 Volume:30 Page:621-631
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Li Qing,Zhou Zhi-Wei,Lu Jia,Luo Hao,Wang Shu-Nan,Peng Yu,Deng Meng-Sheng^ORCID,Song Guan-Bin^ORCID,Wang Jian-Min,Wei Xi,Wang Dong,Westover Kenneth D.,Xu Cheng-Xiong

Funder

NIH

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference28 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int. J. Cancer,2019

2. Gastric Cancer: How Can We Reduce the Incidence of this Disease?;den Hoed;Curr. Gastroenterol. Rep.,2016

3. Progress in the treatment of advanced gastric cancer;Song;Tumour Biol.,2017

4. Efficacy and safety of anti-PD-1/PD-L1 agents vs chemotherapy in patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysis;Wang;Medicine (Baltimore),2019

5. Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial;Fuchs;JAMA Oncol.,2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomics analysis of LINC02202/XBP1 axis in melanoma: Implications for drug targeting and PD‐1 monoclonal antibody efficacy;Journal of Cellular and Molecular Medicine;2024-03-23

2. Implication of PD‑L1 polymorphisms rs2297136 on clinical outcomes of patients with advanced NSCLC who received PD‑1 blockades: A retrospective exploratory study;Oncology Letters;2024-02-07

3. Advances in Immunotherapy and Efficacy Prediction for Gastric Cancer;Advances in Clinical Medicine;2024

4. Astragaloside IV-PESV Repressed T Cell Immunosuppression by Inhibiting PD-L1 Expression in Prostate Cancer through STAT3 Pathway;Journal of Food Biochemistry;2023-11-22

5. Resistance to immune checkpoint inhibitors in gastric cancer;Frontiers in Pharmacology;2023-11-13